Related by context. All words. (Click for frequent words.) 71 HuLuc# 70 VEGF receptor 70 CTAP# Capsules 69 MEK inhibitors 69 Fibroblast Growth Factor Receptor 69 selective kinase inhibitor 69 proteasome inhibitor 69 metaglidasen 69 Factor VIIa 68 protein tyrosine phosphatase 1B 68 A3 adenosine receptor 68 PI3K/mTOR 68 selective inhibition 68 JAK#/JAK# 68 vascular disrupting agents 68 CCR9 antagonist 68 CYT# potent vascular disrupting 68 ENMD # 68 Archexin 68 Alfacell proprietary ribonuclease 68 reversible inhibitor 68 Factor Receptor 68 dasatinib Sprycel 68 JAK1 68 PTP 1B 68 AEG# 68 orally administered inhibitor 67 Eg5 67 accumulate preferentially 67 JAK inhibitors 67 THR beta agonist 67 AAG geldanamycin analog 67 novel VDA molecule 67 specific lectin receptors 67 mTOR inhibitors 67 c MET 67 proteasome inhibitors 67 histone deacetylase HDAC 67 orally bioavailable mimics 67 SERMs 67 epigenetic therapies 67 pathophysiological effects 67 receptor tyrosine kinase inhibitor 67 mTOR kinase 67 HCV protease inhibitors 67 sodium glucose cotransporter 67 kidney urologic 67 investigational humanized monoclonal antibody 67 TLR9 agonist 67 EGFr 67 AEGR 67 Vidofludimus 67 oral kinase inhibitor 67 PI3K inhibitors 67 oral prodrug 67 humanized monoclonal antibodies 66 targeting CD# 66 FGFR 66 antimitotic 66 potently inhibited 66 Granulocyte Colony Stimulating Factor 66 pan HDAC inhibitor 66 secretory phospholipase A2 66 immune modulators 66 IAP inhibitor 66 HDAC6 66 effector function 66 monoclonal antibody MAb 66 endothelin receptor antagonists 66 hormone gastrin 66 Locked Nucleic Acid LNA 66 M2 subunit 66 Janus Kinase 66 sPLA2 66 Xanafide 66 heparanase 66 CCX# 66 Hsp# inhibitors 66 alpha folate receptor 66 PEG SN# 66 Janus kinase 66 Omacetaxine 66 epithelial tumors 66 CCR9 66 DNA methyltransferases 66 diarrhea predominant irritable 66 protein kinase inhibitors 66 Symadex 66 selective antagonist 66 delafloxacin 66 VEGF receptors 66 HDAC enzymes 66 novel peptide 66 immunomodulatory 66 Squalamine 66 Pertuzumab 66 HER1 66 Epothilones 66 MTP inhibitor 65 p# inhibitor 65 PNP inhibitor 65 cyclin dependent kinases 65 direct thrombin inhibitors 65 Galectins 65 DOS# 65 HGS ETR2 65 histone deacetylase HDAC inhibitor 65 poly ADP ribose polymerase 65 inhibiting tumor 65 HDAC 65 imatinib Gleevec ® 65 proliferator activated receptor 65 PRT# 65 isoform selective 65 CD# antibodies 65 targeted antifolate 65 PDGFR 65 Epidermal Growth Factor Receptor 65 PROSTASCINT R 65 targeted radiotherapeutic 65 CBLC# 65 biologic therapeutics 65 Protein Kinase C 65 HSP# inhibitor 65 Hsp# Inhibitor 65 ErbB3 HER3 65 HDACi 65 MEK ERK 65 glucagon receptor 65 chemotherapy induced neutropenia 65 Blinatumomab 65 chemically modified siRNA 65 DNA intercalator 65 ATL/TV# 65 CD# expressing 65 liposomal formulation 65 tubulin inhibitor 65 humanized monoclonal antibody 65 highly selective endothelin 65 phosphoinositide 3 65 ALN TTR 65 CD# CEA 65 cytoprotective 65 cobiprostone 65 pro angiogenic 65 TNF α 65 Fc fusion protein 65 phosphate S1P 65 EGFR HER2 65 highly selective inhibitor 65 selective modulator 65 CD3 monoclonal antibody 65 metastatic colorectal 65 BRAF kinase 65 Panzem R 65 Carfilzomib 65 certain protein tyrosine 65 histone deacetylase 65 Panzem 65 VEGFR 65 depsipeptide 65 leukotriene pathway 65 CYP#A# CYP#D# 65 gefitinib Iressa 65 drug conjugate 65 B lymphocyte stimulator 65 sunitinib malate 65 Solazed TM 65 oncolytic viruses 65 chemokine receptor 65 Bezielle 65 mTOR mammalian target 65 anti CD3 65 castrate resistant prostate cancer 65 novel topoisomerase 65 methionine aminopeptidase 65 acid phosphatase PAP 65 delta gamma agonist 65 OMP #M# 64 MGd 64 TNF alpha selectively neutralizing 64 kinase inhibitors 64 cMET 64 dual PPAR peroxisome 64 JAK3 64 histone methyltransferases HMTs 64 mitotic kinesin 64 mertansine 64 PI3 kinase 64 thromboxane A2 64 HGS ETR1 64 selective inhibitor 64 vidofludimus 64 PDX pralatrexate 64 Nexavar ® 64 Gefitinib 64 prostate cancer antigen prostatic 64 rxRNA 64 5 HT2C receptor 64 Immunotherapeutic 64 FLT3 64 Xyfid TM 64 sorafenib tablets 64 effector functions 64 Ep CAM 64 3 kinase PI3K 64 partial agonist 64 ALN PCS 64 rhIL 7 64 PXD# 64 investigational therapies 64 Bruton tyrosine kinase 64 antitumor efficacy 64 c Raf kinase 64 IAP inhibitors 64 histone deacetylase inhibitor 64 immune modulating 64 Interferon alfa 64 intracellular uptake 64 immunotoxins 64 XmAb# 64 Fleximer 64 thymidylate synthase TS 64 EGFR HER 64 sargramostim 64 TRAIL receptor antibodies 64 HepDirect 64 neuronal nitric oxide synthase 64 LHRH antagonists 64 selectively inhibited 64 apolipoprotein B 64 IMA# 64 selective agonist 64 selective androgen receptor modulators 64 HCV polymerase 64 myelofibrosis polycythemia vera 64 Tyrima 64 CDK inhibitor 64 JAK inhibitor 64 Nanobody ® 64 oncolytic virus therapies 64 CD4 monoclonal antibody 64 XmAb 64 FOLOTYN ® 64 cancer immunotherapies 64 SinuNase ™ 64 selective androgen receptor modulator 64 Enzastaurin 64 anticancer agents 64 CD# monoclonal antibody 64 alvespimycin 64 cytolytic 64 Kinase Inhibitor 64 novel histone deacetylase 64 polymerase inhibitors 64 induce apoptosis 64 nanomolar 64 imatinib Gleevec 64 hypoxia inducible factor 64 RAS MAPK pathway 64 CCR2 64 antiproliferative effects 64 synthetic siRNA 64 epothilone 64 p# mitogen activated 64 IKK epsilon 64 protein kinase inhibitor 64 rNAPc2 64 gemcitabine cisplatin 64 Aplidin 64 combinability 64 multi kinase inhibitor 64 Curaxins 64 HGS# 64 IgG1 antibody 64 5 HT2B receptor 64 FBPase 63 sunitinib Sutent ® 63 humanized anti 63 PORxin TM 63 oral proteasome inhibitor 63 TLR9 63 PDE4 inhibitor 63 TNF Tumor Necrosis Factor 63 erlotinib Tarceva ® 63 CORT # 63 investigational monoclonal antibody 63 renin inhibitor 63 cutaneous T 63 LNP formulations 63 ganetespib 63 INT# [002] 63 Darapladib 63 Ad5FGF 4 63 arterial thrombosis 63 Intravenous CP 63 XL# XL# 63 Personalized Immunotherapy 63 cathepsins 63 potent antiproliferative 63 Vandetanib 63 NTDDS 63 mGluR2 NAM 63 forodesine 63 serine proteases 63 non thiazolidinedione TZD 63 BRAF inhibitor 63 antithrombotic 63 antiangiogenic 63 Zorbtive TM 63 insulin sensitizers 63 Preclinical studies suggest 63 NeoLipid R 63 colorectal bladder 63 Bafetinib 63 Elagolix 63 mu opioid receptor antagonist 63 peroxisome proliferator activated 63 Insegia 63 TNFa 63 Tumor Necrosis Factor 63 CEQ# 63 PKC# 63 oral picoplatin 63 potently inhibit 63 BAY #-# 63 secretory phospholipase A2 sPLA2 63 interleukin IL 63 Histone Deacetylase 63 cholesteryl ester transfer 63 5 HT4 receptor 63 Anticalin ® 63 xenograft models 63 immunomodulating 63 ligand TRAIL 63 pro apoptotic 63 RGB # 63 sodium glucose transporter 63 GMX# 63 Neulasta ® 63 5 HT2A serotonin 63 humanized monoclonal 63 elotuzumab 63 therapeutic monoclonal antibody 63 LY# [003] 63 multitargeted 63 inhibit replication 63 phosphatidylinositol 3 63 SGLT 2 63 DAVANAT 63 Presents Preclinical Data 63 vinca alkaloid 63 Azedra 63 Dasatinib 63 miR #a [002] 63 Onconase 63 MAGE A3 ASCI 63 Darinaparsin 63 AQ4N 63 radiation sensitizer 63 Talabostat 63 anticancer therapeutics 63 VEGF inhibitors 63 KSP inhibitors 63 Irinotecan 63 TKM ApoB 63 ESBA# 63 DNA methyltransferase inhibitors 63 EphA2 63 oxidative stress inducer 63 ARRY # 63 mAbs 63 Taxanes 63 MAb 63 thalidomide Thalomid 63 Sudhir Agrawal D.Phil 63 ® bortezomib 63 Aliskiren 63 cyclin dependent kinase inhibitor 63 Rigel R# 63 kinase inhibition 63 gastrin 63 Monoclonal Antibody 63 chemokine receptors 63 #HT#A 63 Fenretinide 63 HER2 overexpression 63 Elotuzumab 63 small molecule tyrosine 63 agonistic human 63 receptor agonists 63 dependent cellular cytotoxicity 63 Curaxin CBLC# 63 Recombinant Human 63 familial amyloidotic polyneuropathy FAP 63 clinically validated targets 63 sphingosine 1 63 MKC# MKC# PP 63 alpha#beta# 63 Exelixis XL# 63 SGLT2 63 beta Estradiol 63 2 inhibitor CYT# 63 erlotinib Tarceva 63 humanized antibody 63 RANK Ligand 63 5 HT2A receptor 63 DiLA2 63 cleavable linker 63 skeletal metastases 63 RNAi therapeutic targeting 63 atacicept 63 Amrubicin 63 CCR1 63 HDAC Inhibitor 63 antisense oligonucleotides 63 Vascular Endothelial Growth 63 HDAC inhibition 63 Ecallantide 63 non nucleoside HCV 63 SARMs 63 NS#/#A protease 63 teriflunomide 63 Hepatitis C Virus HCV 63 enhance ApoA 63 histone deacetylase HDAC inhibitors 63 Pralatrexate 63 Tß4 63 factor VIIa 63 Fleximer R 63 evaluating tivozanib 63 TG# [003] 63 immunoconjugate 63 NS5b 63 Anticalin R 63 S/GSK# 63 dasatinib Sprycel ® 63 G Protein Coupled 63 MCSP respectively 63 tumor xenograft models 63 FUSILEV enhances 63 RAS RAF MEK 63 Otelixizumab 63 ErbB2 positive 63 r hGH 63 Epratuzumab 63 lumiliximab 63 delipidation 63 ara C 63 PPARg 63 chemopreventive agent 63 PEGylated Fab fragment 63 Angiotensin converting enzyme 63 5alpha reductase 63 gastro intestinal inflammation 63 ceftazidime 63 epothilones 63 interleukin IL -# 63 Zysolin TM 63 ABLYNX 62 HQK 62 beta 1a 62 Th2 cytokines 62 EpCAM 62 antisense compounds 62 bioactive lipids 62 potent inhibitor 62 Dapagliflozin 62 molecular biomarkers 62 immunotherapeutics 62 cortisol synthesis 62 immunostimulatory 62 K ras mutations 62 CYP#A# substrate 62 ERK1 2 62 histone deacetylase inhibitors 62 Exelixis compounds 62 glycoprotein GP IIb IIIa 62 antisense inhibitors 62 MET amplification 62 related apoptosis inducing 62 tyrosine kinase inhibitor 62 immune modulatory 62 Anti Tumor 62 Epigenomics proprietary 62 CG# [003] 62 vWF 62 selective inhibitors 62 drug zotarolimus 62 mimetics 62 B Raf 62 Cloretazine 62 fluoropyrimidine 62 CIMZIA ™ 62 gemcitabine Gemzar 62 Tasimelteon 62 peripherally acting 62 TGR5 62 VEGFR2 62 GRN#L 62 PIGF 62 Silodosin 62 CD# antibody [001] 62 Romidepsin 62 VentiRx Pharmaceuticals 62 HMG CoA reductase inhibitors 62 TPI ASM8 62 velafermin 62 chimeric monoclonal antibody 62 mda 7 62 anticancer therapies 62 Fidaxomicin 62 flavopiridol 62 torezolid 62 antitumor 62 selectively inhibits 62 metastatic neuroendocrine tumors 62 Azedra TM 62 MKC# MT 62 Panzem R NCD 62 IMiDs 62 deacetylase inhibitors 62 nucleotide analog 62 C5aR 62 PI3K inhibitor 62 LymphoStat B belimumab 62 DXL# 62 NNRTIs 62 AVONEX ® 62 neuroprotective properties 62 IGF 1R 62 adecatumumab MT# 62 RAF kinase 62 antibody MAb 62 XmAb ® 62 serine protease 62 Pazopanib 62 P#X# 62 agonist compounds 62 cyclooxygenase 62 dihydrofolate reductase 62 nucleoside analogues 62 BCR ABL inhibitors 62 PARP inhibitors 62 cytokines chemokines 62 CB2 receptor selective 62 OMNARIS HFA 62 insulin sensitizing 62 product platforms AZX# 62 p# MAP kinase 62 TCF#L# 62 Aurora kinase 62 immunomodulator 62 anionic backbone 62 encapsulates siRNAs 62 uPA 62 ANAVEX #-# [001] 62 immunomodulation 62 Cytochrome P# 62 antagomirs 62 Adnectin 62 NEUGENE 62 thrombopoietin 62 Kinoid 62 angiogenesis inhibitors 62 prescribed proton pump 62 tyrosine kinase receptor 62 tyrosine kinase inhibitors 62 HDAC inhibitor 62 IMiDs R 62 Phase 2a Clinical Trial 62 cetuximab Erbitux R 62 demonstrated antitumor activity 62 Curaxin 62 RON Notch 62 lexidronam injection 62 HCV protease 62 TRAIL receptor 62 IFN α 62 ErbB3 62 ThermoDox ® clinical 62 antitumoral 62 Novel Oral 62 CA4P 62 IRX 2 62 sapacitabine CYC# 62 small molecule inhibitors 62 INGN 62 TRAIL R2 62 cathepsin K inhibitor 62 PLX MS 62 AKT inhibitor 62 BrachySil TM 62 Cathepsin S 62 EGFR antibodies 62 Reports Preclinical Data 62 Vidaza ® 62 S#P# 62 Nanobody 62 Zolinza 62 MEK inhibitor 62 Leukine ® 62 DCVax R 62 IL 1ß 62 vesicular monoamine transporter 62 Bicifadine 62 oral JAK1 62 colorectal carcinoma 62 #ME# 62 Anticalins R 62 acetonide FA 62 milatuzumab 62 immune stimulatory 62 radiolabeled monoclonal antibody 62 Upregulation 62 GCase 62 EGF receptor 62 DFMO 62 Cardiotoxicity 62 Zemiva TM 62 kinase PI3K Akt pathway 62 HepaLife PICM 62 Phase #b/#a clinical 62 catalytic antioxidant compounds 62 GSK3B 62 platform HDL Mimetic 62 CCX# B 62 Interferon alpha 62 DU #b 62 CYC# 62 Vidaza azacitidine 62 5 Fluorouracil 62 UsiRNAs 62 CCR5 antagonist 62 mitogen activated ERK kinase 62 PI3 K 62 GVAX ® 62 cell adhesion molecule 62 bFGF 62 cytotoxics 62 prostanoid 62 therapeutic peptide 62 EZN 62 ansamycin 62 miRs 62 muscarinic receptor agonist 62 Aurora Kinase 62 anti amnesic 62 Gleevec resistant 62 lymphoid malignancies 62 volociximab 62 oncolytic 62 R Saizen R 62 ALN HPN 62 Sym# 62 HepDirect prodrug 62 vorinostat 62 Deforolimus 62 tumor hypoxia 62 INCB# [001] 62 MT# MEDI 62 neuropathic pain metabolic diseases 62 5 HT3 receptor 62 IL #p# 62 nucleoside analog 62 Cobalamin TM mediated 62 enzastaurin 62 MAXY G# 62 Interferon beta 62 neuro inflammatory 62 androgen independent 62 visilizumab 62 Varespladib 62 Vicinium TM 62 JAK2 Inhibitor 62 Smac mimetic 62 mycophenolate mofetil 62 carcinoembryonic antigen 62 FVIIa 62 immune modulator 62 non nucleoside inhibitor 61 personalized immunotherapy 61 histone deacetylases 61 azoles 61 triggers apoptosis programmed 61 ON #.Na 61 secreted protein 61 Ceflatonin R 61 TKB# 61 signal transduction inhibitors 61 Cytotoxic 61 fibrotic disease 61 Receptors GPCRs 61 Ozarelix 61 Elacytarabine 61 antibody MT# 61 TMEM#B 61 reslizumab 61 ATL# [001] 61 5 HT3 antagonist 61 inducible nitric oxide synthase 61 polyglutamate 61 stable nucleic acid 61 Pharmos proprietary 61 JAK2 inhibitor 61 TO AVOID PREGNANCY WHILE 61 acadesine 61 alpha#beta# integrin 61 inverse agonist 61 sphingosine kinase 61 VeriStrat 61 Hsp# inhibition 61 HuMax 61 tigecycline 61 Lisofylline 61 detection reagents 61 EGFR pathway 61 siRNA therapeutics 61 pharmacological chaperone 61 Tarmogen 61 cytokines IL 61 polysaccharide polymer 61 antiangiogenic agent 61 Maribavir 61 Lubiprostone 61 PDGF receptor 61 myeloproliferative diseases 61 Rebif ® 61 potent suppressor 61 therapeutic monoclonal antibodies 61 tumor vasculature 61 Viprovex TM 61 RLY# 61 selective immunoproteasome inhibitor 61 pancreatic islet beta 61 renin inhibitors 61 HGS ETR1 mapatumumab 61 gamma secretase inhibitor 61 targeted diseased tissues 61 Aurora kinases 61 M# rationally 61 adult mesenchymal stem 61 Traficet EN 61 VAPRISOL 61 Ganciclovir 61 dacetuzumab 61 glioblastoma multiforme GBM 61 SPRYCEL ® 61 beta interferons 61 #T# L1 61 IgG1 61 HIV integrase inhibitors 61 ERK signaling 61 rusalatide acetate 61 molecularly targeted 61 multiple myeloma MM 61 antiangiogenesis 61 triciribine phosphate monohydrate 61 R#/MEM # 61 hypoxia activated prodrug 61 COX2 61 anti mitotic 61 SCH # 61 protein tyrosine kinase 61 angiotensin receptor blocker ARB 61 #beta HSD1 61 adenoviral 61 thymalfasin 61 c MYC 61 telomerase therapeutic 61 eIF 4E 61 vinca alkaloids 61 pertuzumab 61 PRTX 61 Beta catenin pathway 61 alkylating agent 61 liposome encapsulated 61 GRASPA ® 61 mGluR2 61 interferon lambda 61 lipid particles 61 Anavex #-# 61 antiproliferative activity 61 HCV replication 61 cell lymphoma CTCL 61 immunotherapeutic vaccine 61 Ph.D. Targacept 61 BCL2 61 antisense oligonucleotide 61 #beta HSD 1 61 Hsp# inhibitor 61 SGLT 61 lintuzumab SGN 61 leukemia AML 61 PSMA ADC 61 attach auristatin 61 matrix metalloproteases 61 signal transduction inhibitor 61 inhibit vascular endothelial 61 Parathyroid hormone 61 EndoTAG TM 61 Tezampanel 61 adalimumab Humira 61 antiapoptotic 61 panitumumab Vectibix 61 LNPs 61 MyVax R 61 TGF beta1 61 serine threonine 61 non nucleoside 61 Hycamtin ® 61 CEA CD# Her2 61 OXi# 61 non porcine pancreatic 61 lipid lowering therapies 61 Platelet Derived Growth 61 plasmid DNA vaccine 61 IGF IR 61 agent VDA 61 CTGF 61 stem cell pluripotency 61 mTOR inhibitor 61 oral candidiasis 61 receptor antagonists 61 Trastuzumab 61 Pruvel 61 secondary hyperparathyroidism 61 Fulvestrant 61 LDL cholesterol lowering 61 panobinostat 61 preclinical efficacy 61 NS4A 61 PDE4 inhibitors 61 obatoclax 61 orally bioavailable 61 bevacizumab Avastin ® 61 cisplatin resistant 61 KSP inhibitor 61 CIMZIA TM 61 Achieves Primary Endpoint 61 HyACT 61 DG# compounds targeting 61 ribonucleotide reductase clinically validated 61 antibody mediated 61 HDACs 61 antiangiogenic activity 61 Fibroblast 61 Phase 2b Clinical Trial 61 R sorafenib tablets 61 cyclin dependent kinases CDKs 61 Aganocide 61 AMPK activators 61 HIV integrase inhibitor 61 tyrosine kinase inhibitor TKI 61 Flt3 61 Anticalins ® 61 mediated inhibition 61 BLyS specific 61 alagebrium 61 novel immunomodulatory 61 Locked Nucleic Acid 61 protein CETP 61 GW# [003] 61 hematological indications 61 peptidic compound 61 Delta opioid receptor 61 solithromycin 61 Ambrisentan 61 p# inhibitors 61 ISF# 61 Dyax phage display 61 CDKs 61 Darusentan 61 potent inhibitors 61 dihydrofolate reductase DHFR 61 seliciclib CYC# 61 posaconazole 61 macrophage colony stimulating 61 mapatumumab 61 CB2 selective receptor agonist 61 anti angiogenic agents 61 5 HT6 61 activin receptor type 61 YONDELIS 61 Liposomal 61 Survivin 61 peptibody 61 eIF4E 61 TOCOSOL Camptothecin 61 anticancer activity 61 interleukin IL -6 61 Galectin 3 61 polymerase inhibitor 61 Myocet 61 EphB4 61 reversible inhibitors 61 myeloperoxidase 61 IMC A# 61 vivo potency 61 Lixivaptan 61 chemopreventive agents 61 IGF1R 61 isotypes 61 psoriasis rheumatoid arthritis 61 p# alpha [001] 61 PIK3CA 61 TLR8 agonist 61 engineered proteases 61 lenalidomide Revlimid R 61 Virulizin ® 61 Aptivus ® 61 HER3 61 GSTP1 61 irreversible inhibitor 61 VitiGam 61 radiosensitivity 61 myeloproliferative disorders 61 bexarotene 61 colony stimulating factor 61 Oral Fingolimod 61 receptor subtype 61 hTERT 61 NS4B 61 CFTR corrector 61 potent anticancer 61 FasL 61 resolvins 61 Tesmilifene 61 inhibitor RG# 61 seliciclib 61 Lenocta 61 Xcytrin R 61 MORAb 61 CCR3 61 SIRT2 61 PARP inhibitor 61 PSN# [002] 61 AtuRNAi 61 LAB CGRP 61 sarcoma melanoma 61 opioid receptor antagonist 61 HuCAL GOLD R 61 NS5A 61 PDE4 61 JAK2 inhibitors 61 potent inhibition 61 haematopoietic 61 Factor VEGF 61 huC# DM4 61 inhibit EGFR 61 biobetter 61 monoclonal antibody mAb 61 vascular disrupting agent 61 platinum chemotherapeutic 61 factor HGF 61 Exherin TM 61 siRNA therapeutic 61 TRV# [001] 61 Aflibercept 61 nucleosides 61 Phase #/#a trial 61 HIV AIDS neuropathic pain 61 aripiprazole Abilify 61 transthyretin TTR 61 MEK1 61 intracellular signaling pathways 61 Perifosine 61 samarium Sm 61 PLK1 SNALP 61 PI3K/Akt pathway inhibitor 61 anti CD# antibodies 61 TAKSTA 61 LHRH agonists 61 Erlotinib 61 JUVISTA R Human 61 angiogenesis inhibitor 61 tanespimycin 61 cytochrome P# 61 Akt activation 61 TLR9 agonists 61 siRNA conjugates 61 lung pancreatic 61 triple VEGF receptor 61 Tesetaxel 61 nitric oxide donating 61 HDAC inhibitors 61 Davunetide 61 monoclonal 61 hematological tumors 61 Fludara ® 61 microbiological eradication 61 NXL# 61 novel emulsion formulation 61 refractory chronic lymphocytic 61 nucleoside tide analogs 60 metabolite identification 60 PI3 Kinase 60 abnormal p# 60 systemic RNAi therapeutic